Trial Profile
NOBORI-1
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2009
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary) ; Paclitaxel
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms NOBORI-1
- 30 Aug 2009 3-year results were presented at the European Society of Cardiology annual meeting.
- 03 Jun 2009 Part II results were published in Circulation: Cardiovascular Interventions 2: 188-195, No. 3, Jun 2009.
- 08 Nov 2008 2-year results presented at the 81st Annual Scientific Sessions of the American Heart Association.